Cornelius P. McCarthy III, a director of Medpace Holdings, Inc., filed a Form 4 with the SEC on August 11, 2026, disclosing transactions in Medpace Holdings common stock dated August 7, 2026.

Key Highlights

  • Option exercise: McCarthy exercised a stock option (transaction code M) for 3,858 shares of common stock at an exercise price of $84.36 per share on August 7, 2026.
  • Shares sold: McCarthy disposed of 795 shares (transaction code S) at a price of $585.071 per share on August 7, 2026.
  • Remaining ownership: Following both transactions, McCarthy directly holds 13,415 shares of common stock, according to the filing.
  • Option fully vested: The filing notes the exercised stock option "vested in full on May 13, 2021," with an expiration date of May 15, 2027.
  • Post-exercise derivative holdings: The exercised option carries a remaining balance of 0 derivative securities following the transaction.

Medpace Holdings Director McCarthy Exercises Options and Sells Shares in August 2026

According to the Form 4 filed on August 11, 2026, Cornelius P. McCarthy III, identified as a director of Medpace Holdings, Inc. (NASDAQ:MEDP), reported two transactions in the company's common stock, both dated August 7, 2026. The filing was signed by Stephen P. Ewald as attorney-in-fact for McCarthy.

The first transaction was an option exercise (code M) in which McCarthy acquired 3,858 shares of common stock at a price of $84.36 per share. The filing states that the underlying stock option had an exercise price of $84.36 and an expiration date of May 15, 2027, and that the option "vested in full on May 13, 2021." The price of the derivative security at exercise is listed as $0. Following the exercise, McCarthy's direct beneficial ownership stood at 14,210 shares before the second transaction was applied.

The second transaction was a sale (code S) of 795 shares at a price of $585.071 per share. After this disposal, McCarthy's direct beneficial ownership of Medpace Holdings common stock totaled 13,415 shares, as reported in the filing. Both ownership positions are listed as held directly. No indirect beneficial ownership is reported for either transaction.

What Was Disclosed

The filing reports a stock option exercise of 3,858 shares at $84.36 and a sale of 795 shares at $585.071, resulting in direct beneficial ownership of 13,415 shares of Medpace Holdings common stock for director Cornelius P. McCarthy III as of August 7, 2026.